- Montage Technology’s preliminary net income for the first quarter has missed estimates, with a net income of between 210 million and 240 million yuan, against an estimate of 280.7 million yuan.
- YourTextThe preliminary revenue for the company stood at 737 million yuan, also falling short of the estimated 861.3 million yuan.
- The company’s shares have, however, risen by 9.5% to 47.23 yuan, with 21.1 million shares traded.
- The company has an impressive buy rate, with 19 buys and zero holds or sells recorded.
- More details will be provided in a conference call.
“`
A look at Montage Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysing Montage Technology’s long-term outlook using Smartkarma Smart Scores reveals a promising forecast. With a solid score of 5 in Resilience, the company demonstrates strong durability and adaptability in the face of market changes. Coupled with scores of 3 in both Dividend and Growth, Montage Technology shows potential for steady expansion and shareholder returns over time. The company’s momentum score of 3 suggests a moderate but stable trajectory, further bolstering its overall outlook.
Montage Technology Co., Ltd. specializes in manufacturing electronic components, including memory interface chips and consumer electronics cores. Its diverse product range caters to various sectors such as memory, server, and cloud computing. With a balanced scoring profile on key factors like value, dividend, growth, resilience, and momentum, Montage Technology appears well-positioned for sustained growth and stability in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
